Corrigendum to “Revolutionizing cancer treatment: QSAR-optimized sulfonamides as carbonic anhydrase inhibitors”. [J. Adv. Res. 74 (2025) S6]

IF 13 1区综合性期刊 Q1 MULTIDISCIPLINARY SCIENCES

Journal of Advanced Research Pub Date : 2025-10-17 DOI:10.1016/j.jare.2025.09.027

Momen O. Khattab, Eman A. Mowafi, Mariam N. Hamed, Malak A. Mahmoud, Jana I. Hedar, Salma Elmallah

引用次数: 0

Abstract

The authors regret to inform the readers that the Principal Investigator, Dr. Salma Elmallah, was mistakenly listed only as a supervisor and not included in the author list.

查看原文本刊更多论文

“革命性的癌症治疗：qsar优化磺胺类碳酸酐酶抑制剂”的勘误表。[J。第74 (2025)S6号公告]

作者很遗憾地通知读者，首席研究员Salma Elmallah博士被错误地列为导师，而没有被列入作者名单。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Advanced Research Multidisciplinary-Multidisciplinary

CiteScore

21.60

自引率

0.90%

发文量

280

审稿时长

12 weeks

期刊介绍： Journal of Advanced Research (J. Adv. Res.) is an applied/natural sciences, peer-reviewed journal that focuses on interdisciplinary research. The journal aims to contribute to applied research and knowledge worldwide through the publication of original and high-quality research articles in the fields of Medicine, Pharmaceutical Sciences, Dentistry, Physical Therapy, Veterinary Medicine, and Basic and Biological Sciences. The following abstracting and indexing services cover the Journal of Advanced Research: PubMed/Medline, Essential Science Indicators, Web of Science, Scopus, PubMed Central, PubMed, Science Citation Index Expanded, Directory of Open Access Journals (DOAJ), and INSPEC.